EID-2 Antibodies

Santa Cruz Biotechnology features a diverse variety of EID-2 monoclonal antibodies for advanced research in molecular biology. EID-2 Antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EID-2, or E3 ubiquitin ligase EID-2, plays a crucial role in regulating protein degradation and cellular signaling pathways. The involvement of EID-2 in the modulation of gene expression and cell cycle progression highlights its significance in cancer research and other diseases. Understanding EID-2 function is essential for elucidating the mechanisms underlying various cellular processes. EID-2 research continues to reveal new insights into cellular regulation and disease development. Ongoing studies of EID-2 contribute to our understanding of protein degradation pathways and their impact on cellular homeostasis. Research utilizing EID-2 monoclonal antibodies helps advance knowledge about cancer progression and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for EID-2 enable researchers worldwide to advance scientific understanding of cellular processes and disease mechanisms.